[Risks of therapy in infectious shock].
On the basis of their experience in the intensive therapy unit, correlated with modern pharmacokinetic data, the authors discuss the adverse effects induced by polyvalent therapy in septic shock, and which may be listed in the group of iatrogenic pathointerference. To the biochemical and functional alterations of shock may be added the possible effects of antibioticotherapy, corticotherapy, plasma expanders, lipid emulsions, crystalloid solutions, alkaline correcting solutions, osmotic diuretics, oxygenotherapy, vasoactive drugs, heparin and epsilon-amino-caproic acid. The possible summation of these effects should be indicated in the rules for observance by the medical staff of intensive therapy units.
D015119:Aminocaproic Acid / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D005938:Glucocorticoids / Q000009:adverse effects; D005950:Glucose Solution, Hypertonic; D006493:Heparin / Q000009:adverse effects; D006801:Humans; D007049:Iatrogenic Disease; D010102:Oxygen Inhalation Therapy / Q000009:adverse effects; D010952:Plasma Substitutes / Q000009:adverse effects; D012306:Risk; D012772:Shock, Septic / Q000188:drug therapy / Q000628:therapy*; D065227:Transfusion Reaction; D014662:Vasoconstrictor Agents / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D005938:Glucocorticoids; D005950:Glucose Solution, Hypertonic; D010952:Plasma Substitutes; D014662:Vasoconstrictor Agents; D006493:Heparin; D015119:Aminocaproic Acid
Riscurile terapiei în şocul infecţios.